Brief: Cognition Therapeutics Enters Into Controlled Equity Offering Sales Agreement
23/12/2022 21:56
Dec 23 (Reuters) - Cognition Therapeutics Inc CGTX.O :
* COGNITION THERAPEUTICS INC - ENTERED INTO CONTROLLED
EQUITY
OFFERING SALES AGREEMENT WITH CANTOR FITZGERALD & CO. AND B.
RILEY SECURITIES, INC
* COGNITION THERAPEUTICS INC-MAY OFFER, SELL SHARES OF
COMMON
STOCK, HAVING AGGREGATE OFFERING PRICE OF UP TO $40 MILLION
UNDER AGREEMENT
Source: (https://bit.ly/3Wi1pmu)
Further company coverage: CGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cognition Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Cognition rises after FDA backs late-stage trial plan for dementia drug
Brief: Cognition Therapeutics Announces Issuance Of Composition Of Matter Patent, Extending Protection For Zervimesine (CT1812) Through 2045
Brief: Cognition Therapeutics Schedules A Type C Meeting With FDA To Align On Endpoints For Phase 3 Trial Of Zervimesine (Ct1812) In DLB